Clinical Trials

NIH launches long COVID clinical trial for nervous system dysfunction

March 14, 2024 - On March 12, 2024, the NIH announced that it would open another clinical trial on long COVID, evaluating treatment options for COVID-induced autonomic nervous system dysfunction, as part of the Researching COVID to Enhance Recovery (RECOVER) Initiative. The RECOVER initiative has already launched phase 2 clinical trials on other effects of long...

Read More


More Articles

Eli Lilly Gene Therapy Restores Hearing Within 30 Days

by Veronica Salib

On January 23, 2024, Eli Lilly and the Children’s Hospital of Philadelphia announced the success of an experimental gene therapy for patients with genetic hearing loss. According to the press...

FDA Issues Draft Guidance for Using RWD in Medical Device Regulation

by Veronica Salib

On December 18, 2023, the United States Food and Drug Administration (FDA) published a draft guidance called “Use of Real-World Evidence to Support Regulatory Decision-Making for Medical...

Exercise Program Improves Pediatric Cardiometabolic Health

by Veronica Salib

A study published in JAMA Network Open on July 27, 2023, evaluated the effects of implementing an exercise program for overweight and obese children on cardiometabolic and mental health. Researchers...

ctDNA Testing Reduces Time to Treatment for Lung Cancer Patients

by Veronica Salib

A nonrandomized clinical trial published in JAMA Network Open revealed that circulating tumor DNA (ctDNA) before tissue diagnosis can reduce the time to treatment in patients with suspected advanced...

First Lifesaving In Utero Cerebrovascular Surgery Performed in Boston

by Veronica Salib

Earlier this month, researchers and clinicians at Brigham and Women’s Hospital (BWH) and Boston Children's Hospital took part in the first in utero cerebrovascular surgery to correct a deadly...

Duke Medical Imaging Research Creates 64 Million Times Sharper MRI Image

by Hayden Schmidt

Researchers from the Duke Center for In Vivo Microscopy published an ultra-detailed MRI image this week that was generated using a 9.4 Tesla magnet and high-performance computing. The new imaging...

OTC Hearing Aids Are as Effective as Prescription Hearing Aids

by Veronica Salib

A new study by researchers at the University of Colorado and the University of Pretoria determined that over-the-counter (OTC) hearing aids are as effective as prescription hearing aids for managing...

How the Length of Family Meals Impacts Pediatric Diet and Habits

by Veronica Salib

A study published in JAMA Network Open on April 3, 2023, analyzed the effects of family mealtime on pediatric nutrient intake, diet, and eating habits. Researchers determined that increasing the length...

Orchestra BioMed Goes Public After $110 Million PE Fund Raise

by Hayden Schmidt

Orchestra BioMed was introduced on the Nasdaq Global Market this month after completing its combination with the special purpose acquisition company Health Sciences Acquisitions Corporation 2. Gross...

MRI-Guided Radiotherapy Improves Prostate Cancer Outcomes, Comparison

by Veronica Salib

For patients with prostate cancer, magnetic resonance imaging (MRI)-guided radiotherapy led to better outcomes than computed tomography (CT)-guided radiotherapy. This clinical trial supported claims...

FDA Issues Emergency Authorization for Roche’s Monkeypox Test

by Hayden Schmidt

The pharmaceutical company, Roche Holding AG, received emergency use authorization (EUA) from the FDA Tuesday for its cobas MPXV test that successfully detected monkeypox in human trials. The test is...

Obese Participants Achieve Weight Loss in DBS Clinical Trial

by Hayden Schmidt

A study published in Nature this August found that deep brain stimulation (DBS) could successfully reduce instances of loss of control (LOC) eating, one of the common features of binge eating disorder....

Medical Imaging Study Shows Long-Term Implications of COVID-19 Infection

by Hayden Schmidt

A team of German radiologists conducted a small study of adolescents with previous COVID-19 infections and found ventilated and perfused lung parenchyma reductions compared to a healthy control...

Clinical Trial Reconsiders the Effectiveness of Colonoscopies

by Hayden Schmidt

Colonoscopies have long been a recommended preventive care measure for adults aged 45–75; however, a new study found that they are less beneficial than previously thought. The Nordic-European...

AACE Updates Clinical Practice Guidelines for Diabetic Neuropathy

by Veronica Salib

In a press statement released on October 3, 2022, the Nevro Corporation announced that the American Society of Clinical Endocrinology (AACE) updated its clinical practice guidelines for diabetic...

UC Davis Health Provides Update on In Utero Stem Cell Treatment

by Veronica Salib

In the spring of 2021, the CuRe trial — also known as the Cellular Therapy for In Utero Repair of Myelomeningocele trial — was launched by UC Davis Health. Through this trial, 35 patients...

FDA Approves New MRI Contrast Agent for Nervous System Imaging

by Hayden Schmidt

A new macrocyclic gadolinium-based contrast agent created by Bracco Diagnostics Inc. gained FDA approval last week after a positive Phase III study. The Vueway injection will be available for adult and...

Bluebird’s Gene Therapy Costs $3 Million per Treatment

by Veronica Salib

On September 16, 2022, the FDA granted bluebird bio accelerated approval for their gene therapy technology, Skysona. This technology is meant to treat active cerebral adrenoleukodystrophy (CALD) in...

Temperature-Controlled Radiofrequency Device Improves Nasal Obstruction

by Veronica Salib

A recent publication in JAMA Otolaryngology-Head and Neck Surgery analyzed the outcomes of temperature-controlled radiofrequency (TCRF) device treatment for patients with nasal airway obstruction...

Recent Articles